Hamill TG - Search Results

1

Investigation of angiotensin II/AT1 receptors with carbon-11-L-159,884: a selective AT1 antagonist.

Szabo Z, Kao PF, Burns HD, Gibson RE, Hamill TG, Ravert HT, Kim SE, Mathews WB, Musachio JL, Scheffel U, Dannals RF. Szabo Z, et al. Among authors: hamill tg. J Nucl Med. 1998 Jul;39(7):1209-13. J Nucl Med. 1998. PMID: 9669396 Free article.

2

In vivo labeling of angiotensin II receptors with a carbon-11-labeled selective nonpeptide antagonist.

Kim SE, Scheffel U, Szabo Z, Burns HD, Gibson RE, Ravert HT, Mathews WB, Hamill TG, Dannals RF. Kim SE, et al. Among authors: hamill tg. J Nucl Med. 1996 Feb;37(2):307-11. J Nucl Med. 1996. PMID: 8667067 Free article.

3

Development of [11C]L-159,884: a radiolabelled, nonpeptide angiotensin II antagonist that is useful for angiotensin II, AT1 receptor imaging.

Hamill TG, Burns HD, Dannals RF, Mathews WB, Musachio JL, Ravert HT, Naylor EM. Hamill TG, et al. Appl Radiat Isot. 1996 Feb;47(2):211-8. doi: 10.1016/0969-8043(95)00273-1. Appl Radiat Isot. 1996. PMID: 8852629 Free article.

4

18F-FPEB, a PET radiopharmaceutical for quantifying metabotropic glutamate 5 receptors: a first-in-human study of radiochemical safety, biokinetics, and radiation dosimetry.

Wong DF, Waterhouse R, Kuwabara H, Kim J, Brašić JR, Chamroonrat W, Stabins M, Holt DP, Dannals RF, Hamill TG, Mozley PD. Wong DF, et al. Among authors: hamill tg. J Nucl Med. 2013 Mar;54(3):388-96. doi: 10.2967/jnumed.112.107995. Epub 2013 Feb 12. J Nucl Med. 2013. PMID: 23404089 Free PMC article.

5

Non-invasive radiotracer imaging as a tool for drug development.

Gibson RE, Burns HD, Hamill TG, Eng WS, Francis BE, Ryan C. Gibson RE, et al. Among authors: hamill tg. Curr Pharm Des. 2000 Jul;6(10):973-89. doi: 10.2174/1381612003399987. Curr Pharm Des. 2000. PMID: 10828297 Review.

6

An in vitro assay for predicting successful imaging radiotracers.

Patel S, Hamill T, Hostetler E, Burns HD, Gibson RE. Patel S, et al. Mol Imaging Biol. 2003 Mar-Apr;5(2):65-71. doi: 10.1016/s1536-1632(03)00041-6. Mol Imaging Biol. 2003. PMID: 14499146

7

Positron emission tomography neuroreceptor imaging as a tool in drug discovery, research and development.

Burns HD, Hamill TG, Eng WS, Francis B, Fioravanti C, Gibson RE. Burns HD, et al. Among authors: hamill tg. Curr Opin Chem Biol. 1999 Aug;3(4):388-94. doi: 10.1016/S1367-5931(99)80059-3. Curr Opin Chem Biol. 1999. PMID: 10419855 Review.

8

Kinetic analysis of the cannabinoid-1 receptor PET tracer [(18)F]MK-9470 in human brain.

Sanabria-Bohórquez SM, Hamill TG, Goffin K, De Lepeleire I, Bormans G, Burns HD, Van Laere K. Sanabria-Bohórquez SM, et al. Among authors: hamill tg. Eur J Nucl Med Mol Imaging. 2010 May;37(5):920-33. doi: 10.1007/s00259-009-1340-5. Epub 2009 Dec 24. Eur J Nucl Med Mol Imaging. 2010. PMID: 20033684 Clinical Trial.

9

Synthesis and characterization of a potent, selective, radiolabeled substance-P antagonist for NK1 receptor quantitation: ([18F]SPA-RQ).

Solin O, Eskola O, Hamill TG, Bergman J, Lehikoinen P, Grönroos T, Forsback S, Haaparanta M, Viljanen T, Ryan C, Gibson R, Kieczykowski G, Hietala J, Hargreaves R, Burns HD. Solin O, et al. Among authors: hamill tg. Mol Imaging Biol. 2004 Nov-Dec;6(6):373-84. doi: 10.1016/j.mibio.2004.08.001. Mol Imaging Biol. 2004. PMID: 15564148

10

Species differences in mGluR5 binding sites in mammalian central nervous system determined using in vitro binding with [18F]F-PEB.

Patel S, Hamill TG, Connolly B, Jagoda E, Li W, Gibson RE. Patel S, et al. Among authors: hamill tg. Nucl Med Biol. 2007 Nov;34(8):1009-17. doi: 10.1016/j.nucmedbio.2007.07.009. Epub 2007 Sep 19. Nucl Med Biol. 2007. PMID: 17998106

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

42 results

Search Page

Filters